Keywords: sb/roche, coreg, shows, benefit, advanced, heart, failure

SB/Roche's Coreg shows benefit in advanced heart failure

Article | 31 August 2000

SmithKline Beecham/Roche's beta blocker Coreg (carvedilol; see alsopage 19) has been shown to decrease mortality rates by 35% in patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

Carvedilol

Coreg

Go to drug listing